ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma - Wikidata - wikimedia - TriplyDB

ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma

ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma

http://www.wikidata.org/entity/Q34582105

about

Targeting of erbB3 receptor to overcome resistance in cancer treatment At the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of bone HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models Model-based analysis of HER activation in cells co-expressing EGFR, HER2 and HER3 ERBB3: Multifunctional enabler or primary actor in pancreatic cancer?Targeting ErbB3-mediated stromal-epithelial interactions in pancreatic ductal adenocarcinoma.Anti-tumor efficacy of naked siRNAs for ERBB3 or AKT2 against lung adenocarcinoma cell xenografts.Structural analysis of the EGFR/HER3 heterodimer reveals the molecular basis for activating HER3 mutations Prognosis Relevance of Serum Cytokines in Pancreatic Cancer.Flexible targeting of ErbB dimers that drive tumorigenesis by using genetically engineered T cells.Schedule-dependent cytotoxic synergism of pemetrexed and erlotinib in BXPC-3 and PANC-1 human pancreatic cancer cells.Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells Insights into erlotinib action in pancreatic cancer cells using a combined experimental and mathematical approach.The retinoic acid derivative, ABPN, inhibits pancreatic cancer through induction of Nrdp1 Activation of PDGFr-β Signaling Pathway after Imatinib and Radioimmunotherapy Treatment in Experimental Pancreatic Cancer.Dual targeting of ErbB-2/ErbB-3 results in enhanced antitumor activity in preclinical models of pancreatic cancer.Pertuzumab in gastrointestinal cancer.Resolution of Novel Pancreatic Ductal Adenocarcinoma Subtypes by Global Phosphotyrosine Profiling.High expression of ErbB3 binding protein 1 (EBP1) predicts poor prognosis of pancreatic ductal adenocarcinoma (PDAC).Advances in Targeting HER3 as an Anticancer Therapy Prognostic significance of serum ERBB3 and ERBB4 mRNA in lung adenocarcinoma patients.

P2860

Q26864668-245276B5-9F3B-473C-B169-A35ED1A65C64 Q26866067-D4530645-4481-406A-B0AD-3AF209BF1CB4 Q27853067-3BDFDBC3-FC83-4E1E-82D9-57E793B7ED33 Q31129446-A69399D9-2CE3-4766-B8B6-24830E8077D8 Q34582111-B2AEE4C0-80C8-4F8B-8DA8-674EEA428AA8 Q35208054-77CB9BF2-EE00-4A63-8376-19BF26EF9086 Q35563891-2EA40BA0-B130-47D5-A326-CCC0257C2A96 Q35820920-E816B965-02D6-4173-A17A-5BBCEC183058 Q35963911-0BC141C0-4BF8-40C4-A8B5-AAF4F8A6FC81 Q36071752-47A4437E-225C-4189-B5A5-EE17673E7E20 Q36230591-A62C15DD-E735-4249-925C-B232AE774A8F Q36356248-469C172C-7717-43F3-B604-E849D80FBE30 Q36410371-13F5E4D0-234C-4CA7-80B7-165E63B50539 Q36851569-29F71C2F-CF38-47F3-95DE-54B1A7A24E69 Q37132792-64170B0C-116C-4B65-9591-5E7C5FDA9813 Q37536346-0E048B61-E73A-4814-8E92-A0AE84969D2C Q38653309-86E330E1-4B61-45C7-AE8B-E7AC1D965EEB Q38766765-5EAB6467-8642-4A1B-8A5B-808945AF2CD8 Q38862381-0EB8883B-8488-4FDD-9DA7-ECD2B299FD99 Q41621146-CE9B018F-50E7-47E9-B416-6835DEF0E5F3 Q47948456-0BE658A4-D45D-4708-BF23-30389626C030

P2860

ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma

http://www.wikidata.org/entity/Q34582105

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma

@ast

ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma

@en

ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma

@nl

type

label

ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma

@ast

ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma

@en

ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma

@nl

prefLabel

ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma

@ast

ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma

@en

ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma

@nl

P1433

Q34582105-A3765250-C71A-442B-A993-7639A4BC5FFA

P1476

Q34582105-7CBFC075-7ACC-4F84-991C-3ADE7FD275DC

P2093

Q34582105-22C7CC48-CF8C-4900-B490-AFE8699919D6

Q34582105-479CECE6-2107-4DEA-BD1F-EDAC4E66BE58

Q34582105-5CBC88C7-B6D1-42A9-BA54-C7164A2ACA67

Q34582105-76AA763B-2CFF-472B-B3F7-64AA4DE8AFFA

Q34582105-8CE9B057-AD0A-4B4C-A421-D1A17566ADAF

Q34582105-9F7DE6E0-9393-463A-8273-0824C6AD0CD6

Q34582105-C3D292CF-7BE5-41AD-85E5-F48F017BBAF9

Q34582105-D1898D7C-2526-4BF8-BE47-A40AA35A0652

P2860

Q34582105-026FE68F-5ED9-4A42-B25E-7AF787F8AF8B

Q34582105-028E3EFC-AE48-402B-A464-7F9EB415999B

Q34582105-13F3E2D7-CA1E-488E-889F-CC21C6D93457

Q34582105-205C2F4D-CEDE-44AC-A71C-A96CE1835D28

Q34582105-233D483D-E7B8-4CD0-83D2-865F36BFBCD2

Q34582105-281ADD97-62F8-4E05-9601-53CD8650D785

Q34582105-321B59F8-C083-4529-935E-1479763A311A

Q34582105-3D54F632-D48E-4003-86C3-20CB317D238F

Q34582105-3E21716A-A771-41CF-8F7F-87E65EB6861C

Q34582105-4458C749-74E6-47DF-B409-45B499CD30CD

P304

Q34582105-1222592B-A928-4D40-9743-6614303507A8

P31

Q34582105-9D9E52D9-2CDC-4F66-B58D-96CE3B6DC695

P356

Q34582105-B482100D-1B0B-4D2C-B07B-6E5BCB197236

P433

Q34582105-4E968EC3-D0A3-474F-88BB-A096AEC1CF80

P478

Q34582105-03280FD3-DF3C-4DF5-B297-AE95DD17A5EC

P577

Q34582105-A45BC171-1F11-4976-9DDA-A83A887BC5F3

P5875

Q34582105-389F2A8F-039B-4258-B8FA-CA7FAFFF423D

P698

Q34582105-F534EDEE-5CA3-4B46-A724-C04793229DF9

P921

Q34582105-021886A4-2BF2-4AD6-8F01-2911FF970DE6

P932

Q34582105-326A9423-A6D3-44AD-BDBA-C5B0DE262AE7

P356

P1433

Cancer Biology and Therapy

P1476

ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma

@en

P2093

Andrew V Kossenkov

http://www.w3.org/2001/XMLSchema#string

Andrey Frolov

http://www.w3.org/2001/XMLSchema#string

Ching-Wei D Tzeng

http://www.w3.org/2001/XMLSchema#string

J Harrison Howard

http://www.w3.org/2001/XMLSchema#string

J Spencer Liles

http://www.w3.org/2001/XMLSchema#string

Juan Pablo Arnoletti

http://www.w3.org/2001/XMLSchema#string

Martin J Heslin

http://www.w3.org/2001/XMLSchema#string

Peter Kulesza

http://www.w3.org/2001/XMLSchema#string

P2860

A quantitative protein interaction network for the ErbB receptors using protein microarrays

The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Untangling the ErbB signalling network

ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2-and heregulin-deficient mice

Cancer statistics, 2009

The ErbB signaling network: receptor heterodimerization in development and cancer

EGF-ERBB signalling: towards the systems level

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase.

P304

555-563

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/CBT.10.6.12532

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45278880

http://www.w3.org/2001/XMLSchema#string

P698

20647770

http://www.w3.org/2001/XMLSchema#string

P921

P932

3040944

http://www.w3.org/2001/XMLSchema#string